🔎 Trials Near Me

Utama › Kanser Paru-paru › Florida › Orlando

Kajian klinikal Kanser Paru-paru di Orlando, FL

21 kajian untuk Kanser Paru-paru sedang mencari peserta di lokasi dalam dan sekitar Orlando (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Mengambil pesertaFasa 1/2
  • Advent Health, Orlando
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

Mengambil pesertaFasa 1/2
  • Clermont Oncology Center ( Site 0041), Clermont · 24 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07286149

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 2
  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Mengambil pesertaFasa 3
  • AdventHealth Cancer Institute, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06765109

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Florida Cancer Specialists, Orlando
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • dan 4 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07222566

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Mengambil pesertaFasa 2/3
  • Clermont Oncology Center, Clermont · 24 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06712316

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Mengambil pesertaFasa 1
  • Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06293898

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Orlando Health Cancer Institute, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Mengambil pesertaFasa 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07038343

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Mengambil pesertaFasa 3
  • Orlando Health Cancer Center, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT07499674

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Orlando Health Cancer Institute, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05624996

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • AdventHealth Celebration, Celebration · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Mengambil pesertaFasa 1/2
  • Clermont Oncology Center, Clermont · 24 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT04198766

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jul 2026 · NCT06060613

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Mengambil pesertaFasa 1/2
  • Orlando Health Cancer Institute, Orlando
Umur 18 hingga 70 · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05361174

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Mengambil pesertaFasa 1
  • Research Site, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06835569

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • AdventHealth Cancer Institute, Celebration · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mac 2026 · NCT05948865

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • Florida Cancer Specialists & Research Institute, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jan 2026 · NCT07181473

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Adventhealth, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Nov 2025 · NCT07231159

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Mengambil pesertaKajian pemerhatian
  • Charter Research, Winter Park · 5 mi jauh
  • I.H.S Health, LLC, Kissimmee · 16 mi jauh
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Mengambil pesertaKajian pemerhatian
  • Orlando VA Healthcare System, Orlando
Umur 29 hingga 85 · Semua jantina · Dikemas kini 13 Nov 2024 · NCT06426628

Kajian Kanser Paru-paru di bandar lain

Kajian lain di Orlando

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.